Aspire Biopharma Announces $5 Million Share Repurchase Program

Aspire Biopharma (ASBP) has authorized a $5 million share repurchase program, signaling the board's confidence in the company's financial position. The move is expected to impact the company's stock price and balance sheet, though no specific timeline for the repurchase was provided.

By Harsh Shukla, SA News Editor · Seeking Alpha · April 27, 2026, 12:39 UTC

Aspire Biopharma Announces $5 Million Share Repurchase Program

Tickers: $ASBP

Topics: board authorization corporate finance stock buyback

Read the full article at Seeking Alpha

More World news

Archer Aviation Enters Multi-Year Partnership with Formula One Seeking Alpha · November 12, 2026, 14:16 UTC
Edgewell Personal Care Announces Quarterly Dividend of $0.15 Per Share Seeking Alpha · November 12, 2026, 14:16 UTC
Hudbay Minerals Announces Quarterly Dividend of CAD 0.01 Per Share Seeking Alpha · November 12, 2026, 14:16 UTC
Warby Parker Unveils AI-Powered Intelligent Eyewear Collection in Partnership with Google and Samsung Seeking Alpha · November 12, 2026, 14:17 UTC
Where Food Comes From Reports Q3 Revenue Growth and Improved Gross Margins Seeking Alpha · November 12, 2026, 14:17 UTC
Medical Care Technologies Inc. Reports Q3 Revenue Growth and Significant Net Income Increase Seeking Alpha · November 12, 2026, 14:17 UTC
Digi International Reports Record Fiscal 2026 Results and Announces Acquisition of Disruptive Technologies Motley Fool · November 12, 2026, 14:15 UTC
U.S. Trade Representative Jamieson Greer to Discuss Tariff Policies and Export Controls CNBC · November 12, 2026, 13:31 UTC
Coinbase CEO Brian Armstrong Discusses Binance Hack and Political Shifts Impacting Crypto CNBC · November 12, 2026, 13:44 UTC
Tradeify Announces Multi-Year Partnership with Inter Miami CF PR Newswire · November 12, 2026, 14:15 UTC